Shares outstanding · 2011–2025
Ligand Pharmaceuticals shares outstanding
19.8M+3.5% · FY2025
Ligand Pharmaceuticals (LGND) reported 19.8M in shares outstanding for fiscal 2025, +3.5% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 19.8M | +3.5% | Open → |
| FY20242024-12-31 | 19.1M | +8.8% | Open → |
| FY20232023-12-31 | 17.6M | +3.6% | Open → |
| FY20222022-12-31 | 17.0M | +1.1% | Open → |
| FY20212021-12-31 | 16.8M | +4.3% | Open → |
| FY20202020-12-31 | 16.1M | −4.4% | Open → |
| FY20192019-12-31 | 16.8M | −19.0% | Open → |
| FY20182018-12-31 | 20.8M | −1.8% | Open → |
| FY20172017-12-31 | 21.1M | +1.1% | Open → |
| FY20162017-02-09 | 20.9M | +4.9% | Open → |
| FY20152015-12-31 | 19.9M | +1.5% | Open → |
| FY20142014-12-12 | 19.6M | −4.7% | Open → |
| FY20132014-02-14 | 20.6M | −3.1% | Open → |
| FY20122012-12-31 | 21.3M | +8.1% | Open → |
| FY20112012-02-01 | 19.7M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +0.0%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ligand Pharmaceuticals shares outstanding |url=https://companiesranked.com/en/company/ligand-pharmaceuticals/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ligand Pharmaceuticals shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/ligand-pharmaceuticals/shares-outstandingBibTeX
@misc{companiesranked-en-company-ligand-pharmaceuticals-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Ligand Pharmaceuticals shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ligand-pharmaceuticals/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000886163-26-000044 · August 7, 2026
{{cite web |title=Ligand Pharmaceuticals shares outstanding — 10-Q (0000886163-26-000044) |url=https://www.sec.gov/Archives/edgar/data/886163/000088616326000044/lgnd-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-07}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.